Literature DB >> 20692501

Transcranial sonography in brain disorders with trace metal accumulation.

Uwe Walter1.   

Abstract

Transcranial sonography (TCS) can detect trace metal accumulation in deep brain structures with higher sensitivity than conventional MRI. Especially, increased iron content in the substantia nigra in Parkinson's disease, increased copper content in the lenticular nucleus (LN) in Wilson's disease and idiopathic dystonia, and increased manganese content in the LN in manganese-induced Parkinsonism were detected with TCS, even in subjects with normal MRI. TCS, therefore, might be useful to detect an increased risk of developing neurological symptoms in relatives of patients with Parkinson's or Wilson's disease. The exact mechanism of how an elevated trace metal content leads to an increased echogenicity needs to be further elucidated. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692501     DOI: 10.1016/S0074-7742(10)90012-3

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  9 in total

1.  Transcranial sonography in manganese-induced parkinsonism caused by drug abuse.

Authors:  M Skowronska; K Dziezyc; A Członkowska
Journal:  Clin Neuroradiol       Date:  2013-09-06       Impact factor: 3.649

Review 2.  Drug Repurposing in Parkinson's Disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

3.  Different mechanisms between copper and iron in catecholamines-mediated oxidative DNA damage and disruption of gene expression in vitro.

Authors:  Yoshihiko Nishino; Motozumi Ando; Rena Makino; Koji Ueda; Yoshinori Okamoto; Nakao Kojima
Journal:  Neurotox Res       Date:  2010-10-30       Impact factor: 3.911

4.  Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson's disease and essential tremor.

Authors:  Ivanka Štenc Bradvica; Ivan Mihaljević; Silva Butković-Soldo; Dragutin Kadojić; Marina Titlić; Mario Bradvica; Kristina Kralik
Journal:  Neurol Sci       Date:  2015-03-19       Impact factor: 3.307

5.  Lenticular nucleus hyperechogenicity in Wilson's disease reflects local copper, but not iron accumulation.

Authors:  Uwe Walter; Marta Skowrońska; Tomasz Litwin; Grażyna Maria Szpak; Katarzyna Jabłonka-Salach; David Skoloudík; Ewa Bulska; Anna Członkowska
Journal:  J Neural Transm (Vienna)       Date:  2014-03-11       Impact factor: 3.575

6.  Value of ultrasound fusion imaging in detecting vascular cerebral white matter pathology.

Authors:  Cornelia Brunner; Stephan Joachim Schreiber; Martin Bokemeyer; Gerhard Ransmayr; Walter Struhal; Elisabeth Daniela Olbert; Naela Alhani; Milan Rastislav Vosko
Journal:  Ultrasound J       Date:  2022-06-17

7.  Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease.

Authors:  Antonio Martin-Bastida; Roberta J Ward; Rexford Newbould; Paola Piccini; David Sharp; Christina Kabba; Maneesh C Patel; Michael Spino; John Connelly; Fernando Tricta; Robert R Crichton; David T Dexter
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

8.  Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients.

Authors:  Isabelle Kühn; Henning Maschke; Annette Großmann; Karlheinz Hauenstein; Marc-André Weber; Uwe K Zettl; Alexander Storch; Uwe Walter
Journal:  Neurol Sci       Date:  2021-11-04       Impact factor: 3.830

9.  ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson's Disease.

Authors:  Shanti Diwakarla; Rachel M McQuade; Remy Constable; Olivia Artaiz; Enie Lei; Kevin J Barnham; Paul A Adlard; Robert A Cherny; Madeleine R Di Natale; Hongyi Wu; Xin-Yi Chai; Victoria A Lawson; David I Finkelstein; John B Furness
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.